000 01163 a2200313 4500
005 20250514112622.0
264 0 _c20000701
008 200007s 0 0 eng d
022 _a0077-8923
024 7 _a10.1111/j.1749-6632.1958.tb42674.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPAPAC, R
245 0 0 _aPreliminary clinical trial of p-di-2-chloroethyl-amino-L-phenylalanine (CB 3025, melphalan) and of di-2-chloroethyl methanesulfonate (CB 1506).
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cApr 1958
300 _a1126-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMechlorethamine
650 0 4 _aMelphalan
650 0 4 _aMesylates
650 0 4 _aNitrogen Mustard Compounds
_xtherapeutic use
650 0 4 _aPhenylalanine
700 1 _aGALTON, D A
700 1 _aTILL, M
700 1 _aWILTSHAW, E
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 68
_gno. 3
_gp. 1126-7
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.1958.tb42674.x
_zAvailable from publisher's website
999 _c13394726
_d13394726